Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Induction of intestinal Th17 cells by segmented filamentous bacteria.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Neurobehavioral disorders.
Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
iPINBPA: AN INTEGRATIVE NETWORK-BASED FUNCTIONAL MODULE DISCOVERY TOOL FOR GENOME-WIDE ASSOCIATION STUDIES.
CXCL13 antibody for the treatment of autoimmune disorders.
T Cell Mediated Pathogenesis in EAE: Molecular Mechanisms.
Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Temporal reorganization to overcome monocular demyelination.
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes.
Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
Spinocerebellar Ataxias Type 8, 12, and 17 and Dentatorubro-Pallidoluysian Atrophy in Czech Ataxic Patients.
Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation.
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily.
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.
Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Constraint-Induced Movement Therapy for the Lower Extremities in Multiple Sclerosis: Case Series with 4-Year Follow-up.

Pages